AAPG

Ascentage Pharma Group International (AAPG)

About Ascentage Pharma Group International (AAPG)

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Details

Daily high

$29.49

Daily low

$29.00

Price at open

$29.37

52 Week High

$48.45

52 Week Low

$17.00

Market cap

2.7B

Dividend yield

0.00%

Volume

2,320

Avg. volume

3,733

P/E ratio

-14.56

Ascentage Pharma Group International News